Martel Hammer Pharmaceuticals Private Limited
About Martel Hammer Pharmaceuticals Private Limited
Data last updated:
Martel Hammer Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Farichem Laboratories Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 January 1977 and has been in existence for over 49 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1977PTC019462. Its GSTIN is 27AABCM0985E1ZJ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Kalpana Umakanth and Prabhudas Kalidas Gohil.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Apeejay Chambers Wallacestreet Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.35 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.81 Lakh (net margin 41.6%) and EBITDA of ₹2.41 Lakh (EBITDA margin 55.4%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹15.35 Lakh and satisfied charges of ₹21.8 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Martel Hammer Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressApeejay Chambers Wallacestreet Fort, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Martel Hammer Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Martel Hammer Pharmaceuticals Private Limited
FY 2025 filings availableMartel Hammer Pharmaceuticals Private Limited reported revenue of ₹4.35 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 19% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 55.4% | ||||
| Net Profit Margin | 41.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Martel Hammer Pharmaceuticals Private Limited, buy the company report.
Board of directors of Martel Hammer Pharmaceuticals Private Limited
Martel Hammer Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kalpana Umakanth Also directs: Linden Properties and Trading LLP, Apeejay Stya Enterprises LLP, Apeejay Stya Knowledge LLP and 5 more | Director | 15 Apr 2013 | 13 Years 6 Months | Current |
| Prabhudas Kalidas Gohil | Director | 15 Jan 1992 | 34 Years 9 Months | Current |
Peer comparison
Martel Hammer Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Weltcare Lifesciences Private Limited | ₹4.38 Lakh (FY 2022) | 142.0% | Pune, Maharashtra, India | |||
| Willius Pharmaceuticals Private Limited | ₹4.37 Lakh (FY 2025) | 395.0% | Jahagirpuri, Delhi, India | |||
| Yeslife Pharmaceuticals Limited | ₹4.37 Lakh (FY 2022) | 119.0% | New Delhi, Delhi, India | |||
| Birmshire Pharmaceuticals Private Limited | ₹4.36 Lakh (FY 2024) | -34.0% | New Delhi, Delhi, India | |||
| Aidsoulasia Pharmaceuticals Private Limited | ₹4.36 Lakh (FY 2023) | -9.0% | Noida, Uttar Pradesh, India | |||
| Martel Hammer Pharmaceuticals Private Limitedthis company | ₹4.35 Lakh (FY 2025) | ₹1.81 Lakh | 41.6% | 19.0% | Mumbai, Maharashtra, India | |
| Markus Pharmaceuticals Private Limited | ₹4.35 Lakh (FY 2023) | Alappuzha, Kerala, India | ||||
| Mediventus Pharmaceuticals Private Limited | ₹4.35 Lakh (FY 2024) | -29.0% | Meerut, Uttar Pradesh, India | |||
| Bismillah Haj Tours and Travels Private Limited | ₹4.34 Lakh (FY 2021) | -99.0% | Pune, Maharashtra, India | |||
| Decor Pharmaceuticals Private Limited | ₹4.34 Lakh (FY 2025) | -65.0% | Lucknow, Uttar Pradesh, India | |||
| Aerocon Pharmaceuticals (OPC) Private Limited | ₹4.34 Lakh (FY 2020) | New Delhi, Delhi, India |
To see the full peer comparison of Martel Hammer Pharmaceuticals Private Limited, buy the company report.
Auditor
Martel Hammer Pharmaceuticals Private Limited is audited by AJAY SEKHRI AND COMPANY for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY SEKHRI AND COMPANY | FY 2020 | 140181W |
Shareholding
The shareholding of Martel Hammer Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Martel Hammer Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Sep 1986 | 90187372 | Punjab National Bank Ltd | ₹10 Lakh | Open | |
| 03 Mar 1981 | 90184614 | Punjab National Bank Ltd | ₹3.35 Lakh | Open | |
| 13 Jul 1977 | 90184410 | Punjab National Bank Ltd | ₹2 Lakh | Open | |
| 05 Aug 1977 | 90184414 | Punjab National Bank Ltd | ₹21.8 Lakh | Satisfied |
To see the full charge records of Martel Hammer Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Martel Hammer Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Martel Hammer Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Martel Hammer Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCM0985E1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Martel Hammer Pharmaceuticals Private Limited, buy the company report.
Recent activity
Martel Hammer Pharmaceuticals Private Limited has 4 board changes on record since 1992: 2 appointments and 2 cessations. The latest: Prakash Chandra Sabherwal ceased to be Director on 12 Mar 2015.
Frequently asked questions
Martel Hammer Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 January 1977 (49+ years old) and is registered under CIN U24230MH1977PTC019462.
Martel Hammer Pharmaceuticals has 2 current directors:
- Kalpana Umakanth - Director
- Prabhudas Kalidas Gohil - Director
The latest financial statements of Martel Hammer Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Martel Hammer Pharmaceuticals is 27AABCM0985E1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Martel Hammer Pharmaceuticals is U24230MH1977PTC019462. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Martel Hammer Pharmaceuticals was incorporated on 27 January 1977, making it 49+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Martel Hammer Pharmaceuticals by revenue are Weltcare Lifesciences Private Limited, Willius Pharmaceuticals Private Limited, Yeslife Pharmaceuticals Limited, Birmshire Pharmaceuticals Private Limited, Aidsoulasia Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Prakash Chandra Sabherwal ceased to be Director on 12 Mar 2015. Kalpana Umakanth was appointed as Director on 15 Apr 2013. Rajesh Ramawatar Sharma ceased to be Director on 15 Apr 2013. Martel Hammer Pharmaceuticals has 4 board changes on record in total.
The registered office of Martel Hammer Pharmaceuticals is at Apeejay Chambers Wallacestreet Fort, Mumbai, Maharashtra, India – 400001.
Martel Hammer Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Martel Hammer Pharmaceuticals has open charges of ₹15.35 Lakh and satisfied charges of ₹21.8 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
